IRIS

BRULLO, CHIARA

BRULLO, CHIARA  

100006 - Dipartimento di Farmacia  

Mostra records
Risultati 1 - 20 di 117 (tempo di esecuzione: 0.021 secondi).
Titolo Data di pubblicazione Autore(i) File
1-Methyl and 1-(2-hydroxyalkyl)-5-(3-alkyl/cycloalkyl/phenyl/naphthylureido)-1H-pyrazole-4-carboxylic acid ethyl esters as potent human neutrophil chemotaxis inhibitors 1-gen-2009 Bruno, Olga; Brullo, Chiara; Bondavalli, Francesco; Schenone, Silvia; Spisani, S; Falzarano, Ms; Varani, K; Barocelli, E; Ballabeni, V; Giorgio, C; Tognolini, M.
2-Amino/Azido/Hydrazino-5-alkoxy-5H-[1]benzopyrano[4,3-d]pyrimidines: Synthesis and Pharmacological Evaluation 1-gen-2007 Bruno, Olga; Brullo, Chiara; Bondavalli, Francesco; Ranise, Angelo; Schenone, Silvia; M., Tognolini; V., Ballabeni; E., Barocelli
2-Aryl-3-phenylamino-4,5-dihydro-2h-benz[g]indazoles with analgesic activity 1-gen-2003 Schenone, Silvia; Bruno, Olga; Ranise, Angelo; Brullo, Chiara; Bondavalli, Francesco; W., Filippelli; F., Mazzeo; A., Capuano; G., Falcone
2-Phenyl-2,3-dihydro-1H-imidazo[1,2-b]pyrazole derivatives: New potent inhibitors of fMLP-induced neutrophil chemotaxis 1-gen-2007 Bruno, Olga; Brullo, Chiara; Bondavalli, Francesco; Ranise, Angelo; Schenone, Silvia; Falzarano, M. S.; Varani, K; Spisani, S.
3D QSAR models built on structure-based alignments of Abl tyrosine kinase inhibitors. 1-gen-2009 F., Falchi; F., Manetti; F., Carraro; A., Naldini; G., Maga; E., Crespan; Schenone, Silvia; Bruno, Olga; Brullo, Chiara; M. Botta, .
A combination strategy to inhibit Pim-1: synergism between noncompetitive and ATP-competitive inhibitors. 1-gen-2013 Mori, M; Tintori, C; Christopher, Rs; Radi, M; Schenone, Silvia; Musumeci, Francesca; Brullo, Chiara; Sanità, P; Delle Monache, S; Angelucci, A; Kissova, M; Crespan, E; Maga, G; Botta, M.
A Proteomics Approach Identifies RREB1 as a Crucial Molecular Target of Imidazo–Pyrazole Treatment in SKMEL-28 Melanoma Cells 1-gen-2024 Iervasi, Erika; Coronel Vargas, Gabriela; Bachetti, Tiziana; Tkachenko, Kateryna; Spallarossa, Andrea; Brullo, Chiara; Rosano, Camillo; Carta, Sonia; Barboro, Paola; Profumo, Aldo; Ponassi, Marco
A1 receptors ligands: past, present and future trends. 1-gen-2010 Schenone, Silvia; Brullo, Chiara; Musumeci, Francesca; Bruno, Olga; Botta, M.
Ablation of specific long PDE4D isoforms increases neurite elongation and conveys protection against amyloid-β pathology 1-gen-2023 Paes, D.; Schepers, M.; Willems, E.; Rombaut, B.; Tiane, A.; Solomina, Y.; Tibbo, A.; Blair, C.; Kyurkchieva, E.; Baillie, G. S.; Ricciarelli, R.; Brullo, C.; Fedele, E.; Bruno, O.; van den Hove, D.; Vanmierlo, T.; Prickaerts, J.
Amelioration of functional and histopathological consequences after spinal cord injury through phosphodiesterase 4D (PDE4D) inhibition 1-gen-2024 Schepers, M.; Hendrix, S.; Mussen, F.; van Breedam, E.; Ponsaerts, P.; Lemmens, S.; Hellings, N.; Ricciarelli, R.; Fedele, E.; Bruno, O.; Brullo, C.; Prickaerts, J.; Van Broeckhoven, J.; Vanmierlo, T.
Amino-Pyrazoles in Medicinal Chemistry: A Review 1-gen-2023 Lusardi, Matteo; Spallarossa, Andrea; Brullo, Chiara
An update on dual Src/Abl inhibitors 1-gen-2012 Musumeci, Francesca; Schenone, Silvia; Brullo, Chiara; Botta, M.
An Update on JAK Inhibitors 1-gen-2019 Musumeci, Francesca; Greco, Chiara; Giacchello, Ilaria; Fallacara, Anna Lucia; Ibrahim, Munjed M; Grossi, Giancarlo; Brullo, Chiara; Schenone, Silvia
Analogs, formulations and derivatives of imatinib: A patent review 1-gen-2015 Musumeci, Francesca; Schenone, Silvia; Grossi, Giancarlo; Brullo, Chiara; Sanna, Monica
Anticancer Effects of the Novel Pyrazolyl-Urea GeGe-3 1-gen-2024 Williams, ; Cooper, E.; Clark, B.; Perry, L.; Ponassi, M.; Iervasi, E.; Brullo, C.; Greenhough, A.; Ladomery, M.
Antimicrobial Evaluation of New Pyrazoles, Indazoles and Pyrazolines Prepared in Continuous Flow Mode 1-gen-2023 Burke, Adam; Di Filippo, Mara; Spiccio, Silvia; Schito, ANNA MARIA; Caviglia, Debora; Brullo, Chiara; Baumann, Marcus
Antiproliferative Imidazo-Pyrazole-Based Hydrogel: A Promising Approach for the Development of New Treatments for PLX-Resistant Melanoma 1-gen-2023 Alfei, Silvana; Milanese, Marco; Brullo, Chiara; Valenti, Giulia Elda; Domenicotti, Cinzia; Russo, Eleonora; Marengo, Barbara
ATP-competitive inhibitors of mTOR: an update. 1-gen-2011 Schenone, Silvia; Brullo, Chiara; Musumeci, Francesca; Radi, M; Botta, M.
Bcr-Abl tyrosine kinase inhibitors: A patent review 1-gen-2015 Desogus, Andrea; Schenone, Silvia; Brullo, Chiara; Tintori, Cristina; Musumeci, Francesca
Biological evaluation of pyrazolyl-urea and dihydro-imidazopyrazolyl-urea derivatives as potential anti-angiogenetic agents in the treatment of neuroblastoma 1-gen-2020 Marengo, B.; Meta, E.; Brullo, C.; de Ciucis, C.; Colla, R.; Speciale, A.; Garbarino, O.; Bruno, O.; Domenicotti, C.